Published in Eur Respir J on June 01, 2009
Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis (2011) 2.59
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91
Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery. Clin Microbiol Rev (2011) 1.01
The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes. Int J Tuberc Lung Dis (2011) 0.95
A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis. PLoS One (2013) 0.89
Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy. Eur J Clin Microbiol Infect Dis (2011) 0.86
Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production. J Clin Microbiol (2014) 0.81
Molecular characterization of T cell receptor beta variable in the peripheral blood T cell repertoire in subjects with active tuberculosis or latent tuberculosis infection. BMC Infect Dis (2013) 0.78
TB or not TB? Difficulties in the diagnosis of tuberculosis in HIV-negative immigrants to Germany. Eur J Med Res (2011) 0.78
Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis. PLoS One (2017) 0.75
Insight into the diagnosis and management of subclinical genital tuberculosis in women with infertility. J Hum Reprod Sci (2016) 0.75
IFN-γ and IL-2 Responses to Recombinant AlaDH against ESAT-6/CFP-10 Fusion Antigens in the Diagnosis of Latent versus Active Tuberculosis Infection. Iran J Med Sci (2017) 0.75
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA (2000) 8.42
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess (2007) 5.29
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis (2006) 5.08
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J (2010) 4.72
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J (2008) 4.32
Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis (2007) 4.04
One hundred questions of importance to the conservation of global biological diversity. Conserv Biol (2009) 3.95
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J (2010) 3.81
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J (2007) 3.67
Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis (2007) 3.25
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J (2009) 3.16
Structure at 2.3 A resolution of the cytochrome bc(1) complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. Structure (2000) 3.03
Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax (2001) 3.01
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J (2009) 2.92
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet (2000) 2.74
A heat shock following electroporation induces highly efficient transformation of Corynebacterium glutamicum with xenogeneic plasmid DNA. Appl Microbiol Biotechnol (1999) 2.58
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. J Thromb Haemost (2006) 2.57
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J (2007) 2.46
Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A (1997) 2.38
Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J (2010) 2.38
Recognizing emergency medicine in India. Natl Med J India (2001) 2.27
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. Eur Respir J (2008) 2.23
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax (2005) 2.09
The diagnosis and misdiagnosis of tuberculosis. Int J Tuberc Lung Dis (2008) 2.09
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J (2009) 2.07
Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J (2011) 2.07
Tuberculosis control in Europe and international migration. Eur Respir J (1994) 2.07
Tuberculous meningitis. J Neurol Neurosurg Psychiatry (2000) 2.05
Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction. J Am Coll Cardiol (1998) 2.02
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J (2009) 2.01
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia (2011) 2.00
Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med (1997) 1.95
Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. Eur Respir J (2007) 1.81
Treatment of tuberculosis: update 2010. Eur Respir J (2010) 1.79
CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood (2001) 1.74
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect (2011) 1.73
[Sociodemographic characteristics in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) - operationalisation and public health significance, taking as an example the assessment of general state of health]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2007) 1.71
AIDS and hepatitis B in the former Soviet Union. BMJ (1992) 1.65
Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost (2009) 1.63
High risk of tuberculosis in health care workers in Romania. Int J Tuberc Lung Dis (2008) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation. Infect Immun (1998) 1.58
Cost-effectiveness of treating latent tuberculous infection: a step towards elimination? Int J Tuberc Lung Dis (2013) 1.58
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J (2010) 1.57
Comparison of two methods of processing induced sputum: selected versus entire sputum. Am J Respir Crit Care Med (1998) 1.56
Cost-optimisation of screening for latent tuberculosis in close contacts. Eur Respir J (2006) 1.55
Evaluation of strategies for molecular fingerprinting for use in the routine work of a Mycobacterium reference unit. J Clin Microbiol (1998) 1.55
Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res (2006) 1.54
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. J Thromb Haemost (2011) 1.54
Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. Int J Tuberc Lung Dis (2003) 1.52
Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: a systematic review. Int J Tuberc Lung Dis (2007) 1.52
Characterization of a Flavobacterium glutathione S-transferase gene involved reductive dechlorination. J Bacteriol (1993) 1.50
Predicting outcomes and drug resistance with standardised treatment of active tuberculosis. Eur Respir J (2010) 1.49
The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates. Transfusion (1995) 1.49
Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? Eur Respir J (2008) 1.48
Increased risk of tuberculosis among health care workers in Samara Oblast, Russia: analysis of notification data. Int J Tuberc Lung Dis (2005) 1.46
Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet Epidemiol (2002) 1.46
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J (2007) 1.44
Estimation of the rate of unrecognized cross-contamination with mycobacterium tuberculosis in London microbiology laboratories. J Clin Microbiol (2002) 1.44
The use of interferon-gamma-based blood tests for the detection of latent tuberculosis infection. Eur Respir J (2006) 1.42
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int J Tuberc Lung Dis (2000) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med (2000) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Prospective management of a child with neonatal citrullinemia. J Pediatr (1993) 1.39
[Infection diagnostics in pneumology. Part 1. Survey and methods]. Pneumologie (2008) 1.38
Does bleach processing increase the accuracy of sputum smear microscopy for diagnosing pulmonary tuberculosis? J Clin Microbiol (2010) 1.35
Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy (1997) 1.35
Microcolony culture techniques for tuberculosis diagnosis: a systematic review. Int J Tuberc Lung Dis (2011) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Determinants of child nutrition and mortality in north-west Uganda. Bull World Health Organ (1992) 1.32
Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int J Tuberc Lung Dis (2009) 1.30
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Eur Respir J (2012) 1.29
[Health monitoring at the Robert Koch Institute. Status and perspectives]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2009) 1.28
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J (2009) 1.27
Mobile health to improve tuberculosis care and control: a call worth making. Int J Tuberc Lung Dis (2013) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Diagnosis and treatment of tuberculosis in undocumented migrants in low- or intermediate-incidence countries. Int J Tuberc Lung Dis (2008) 1.27
Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting? Eur Respir J (2011) 1.25
Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells. Int J Tuberc Lung Dis (2008) 1.24
Tuberculosis and noncommunicable diseases: neglected links and missed opportunities. Eur Respir J (2010) 1.24
Primary lymphoma of the liver. Cancer (1988) 1.24
Variability in interpretation of chest radiographs among Russian clinicians and implications for screening programmes: observational study. BMJ (2005) 1.24
Survival after cardiopulmonary resuscitation in an urban Indian hospital. Natl Med J India (1999) 1.23